The global antihistamine drugs market, addressing conditions such as rhinitis, conjunctivitis, and dermatitis, witnesses growth driven by the global increase in allergies. Available in various forms, including oral tablets and nasal sprays, antihistamines offer relief from itching, sneezing, and congestion. The growing demand for effective allergy symptom relief drives the market's expansion. Additionally, the versatility of antihistamine drugs in treating conditions such as sleep disorders, motion sickness, and anxiety contributes to their widespread adoption, further fueling consistent market growth.
Data Bridge Market Research analyses that the Global Antihistamine Drugs Market, which was USD 256.26 million in 2022, is expected to reach USD 520.12 million by 2030, at a CAGR of 9.25% during the forecast period of 2023-2030.
"Growing occurrence of allergic reactions drive the market growth"
The rising prevalence of allergic reactions globally drives the antihistamine drugs market. Increased exposure to allergens due to environmental changes, rising pollution, changing lifestyles, and global travel have intensified the demand for effective treatments. As more individuals experience allergies, the need for antihistamine drugs for symptom relief grows. The market's expansion reflects the imperative for solutions to manage allergic reactions, highlighting antihistamine drugs' crucial role in enhancing the quality of life for those affected by allergies.
What restraints the growth of the global antihistamine drugs market?
"Side effects hamper the market growth"
The prevalence of common side effects such as drowsiness, dizziness, and dry mouth associated with antihistamine use poses a deterrent to the market. These adverse effects, particularly the potential for drowsiness, may discourage individuals from utilizing antihistamines, especially when maintaining alertness is essential, impacting their daytime functionality. The prospect of impaired alertness can lead to decreased patient adherence and may prompt individuals to seek alternative treatments, thereby limiting the market potential for antihistamine drugs.
Segmentation: Global Antihistamine Drugs Market
The global antihistamine drugs market is segmented on the basis of type, indication, dosage form, route of administration, end-users, and distribution channel.
- On the basis of type, the global antihistamine drugs market is segmented into prescription-based, over-the-counter (OTC)
- On the basis of indication, the global antihistamine drugs market is segmented into Urticaria, allergy, dermatitis, and others
- On the basis of dosage form, the global antihistamine drugs market is segmented into tablets, capsules, and others
- On the basis of route of administration, the global antihistamine drugs market is segmented into oral, parenteral, and others
- On the basis of end-users, the global antihistamine drugs market is segmented into hospitals, specialty clinics, homecare, and others
- On the basis of distribution channel, the global antihistamine drugs market is segmented into hospital pharmacy, retail pharmacy, online pharmacy, and others
Regional Insights: North America is expected to dominate the Global Antihistamine Drugs Market
North America is expected to dominate the global antihistamine drugs market, driven by major key players' emphasis on novel technology and the region's escalating healthcare expenditure. This strategic focus on advancements and increased investment in healthcare infrastructure contribute to the region's leading position in propelling the growth rate of the antihistamine drugs market. The region's commitment to innovation and substantial healthcare spending underscores its pivotal role in shaping the trajectory of the global market for antihistamine pharmaceuticals.
Asia-Pacific is expected to dominate the global antihistamine drugs market from 2023 to 2030, driven by a surge in the prevalence of allergic reactions in the region. The increasing incidence of allergies necessitates a growing demand for effective treatments, contributing to market expansion. Additionally, the ongoing development of healthcare infrastructure in Asia-Pacific plays a pivotal role, further accelerating the market's growth rate. These factors collectively position the region as a key contributor to the global antihistamine drugs market.
Recent Developments: Global Antihistamine Drugs Market
- In June 2021, the U.S. FDA approved Astepro (azelastine hydrochloride nasal spray, 0.15%) for nonprescription use, providing relief for seasonal and perennial allergic rhinitis in adults and children aged six and older through a partial prescription to nonprescription changeover
To know more about the study, visit https://www.databridgemarketresearch.com/fr/reports/global-antihistamine-drugs-market
The Prominent Key Players Operating In The Global Antihistamine Drugs Market Include:
- Akorn, Incorporated (U.S.)
- Pfizer Inc. (U.S.)
- GlaxoSmithKline plc (U.K.)
- Novartis AG (Switzerland)
- Mylan N.V. (U.S.)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Sanofi (France)
- Boehringer Ingelheim International GmbH. (Germany)
- AstraZeneca (U.K.)
- Johnson & Johnson Private Limited (U.S.)
- Bayer AG (Germany)
- Merck & Co., Inc. (U.S.)
- Prestige Consumer Healthcare Inc. (U.S.)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Bristol-Myers Squibb Company (U.S.)
- Almirall, S.A (Spain)
- Zenomed Healthcare Private Limited (India)
- Cadila Pharmaceuticals (India)
Above are the key players covered in the report, to know about more and exhaustive list of global antihistamine drugs market companies, contact: https://www.databridgemarketresearch.com/fr/contact
Research Methodology: Global Antihistamine Drugs Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
